NPI: 1407130602 · FREMONT, CA 94538 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/06/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/06/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,406 | $897K |
| 2019 | 13,035 | $780K |
| 2020 | 12,340 | $1.08M |
| 2021 | 9,798 | $1.18M |
| 2022 | 13,454 | $1.41M |
| 2023 | 12,105 | $1.55M |
| 2024 | 10,397 | $1.49M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,577 | 2,690 | $8.31M |
| A4657 | Syringe, with or without needle, each | 12,963 | 1,955 | $56K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,883 | 1,263 | $15K |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,894 | 888 | $4K |
| J1756 | Injection, iron sucrose, 1 mg | 5,514 | 1,437 | $4K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,027 | 624 | $1K |
| 90662 | 16 | 16 | $516.33 | |
| 90674 | 27 | 27 | $355.59 | |
| 83970 | 174 | 173 | $235.80 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 42 | 31 | $28.27 |
| 85048 | 298 | 276 | $0.00 | |
| 83540 | 118 | 111 | $0.00 | |
| 85041 | 301 | 279 | $0.00 | |
| 82108 | 18 | 18 | $0.00 | |
| 83550 | 48 | 47 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 86 | 83 | $0.00 |
| 82728 | 118 | 111 | $0.00 | |
| 0250 | 1,416 | 95 | $0.00 | |
| 82746 | 15 | 15 | $0.00 |